Foley & Lardner LLP represented TCGX as co-lead investor. Alkeus Pharmaceuticals closed its $150 million Series B financing for Alkeus Pharmaceuticals. TCGX was joined by Bain...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP recently represented New Enterprise Associates, Inc. as lead investor. Comanche Biopharma closed its $75 million Series B financing. New Enterprise Associates, Inc. acted...
You must be a Standard 1 Year member to access this content.
Foley & Lardner LLP represented Hanwha Impact Partners on the deal. Hanwha Impact Partners acted as lead investor in the $121 million Series C funding round for...
You must be a Standard 1 Year member to access this content.
